U.S. Plasmid DNA Manufacturing Market Enters a New Era of Expansion and Opportunity by 2034
The U.S. plasmid DNA manufacturing market is witnessing substantial growth, driven by the increasing adoption of plasmid production in gene therapy, vaccine development, and other biopharmaceutical applications. The market is expanding as research and development activities intensify and the demand for high-quality DNA vectors rises for advanced therapeutic and diagnostic solutions.
Market...